Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.
Save my name, email, and website in this browser for the next time I comment.
Your Name (required)
Your Email (required)
Subject
Your Message
WhatsApp us
